New Products

SIMI VALLEY, Calif. — Skin care company derma e has introduced its first sun care products — Antioxidant Natural Sunscreen SPF 30 Oil-Free Face Lotion and Body Lotion.
 

WILMINGTON, Del. — AstraZeneca received approval from the Food and Drug Administration for its Bydureon pen (exenatide extended-release for injectable suspension) 2-mg, which is to be used as an addition to diet and exercise to improve glycemic control in adults with Type 2 diabetes.

The Bydureon pen is a pre-filled, single-use pen injector, which eliminates the need for the patient to transfer their medication between a vial and syringe during the process of self-injection. The pen contains the same formula and dose as the original Bydureon single-dose tray.

JERUSALEM — Teva Pharmaceutical Industries announced the launch of Adasuve (loxapine) inhalation powder in a 10-mg dosage. The drug is the first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar disorder in adults.

CINCINNATI — Procter & Gamble’s Oral-B has announced the launch of an oral care app for children — the Disney Magic Timer App by Oral-B.

Created in collaboration with Disney and powered by DreamPlay, the oral care app is designed to helps kids increase brushing time, which is identified by dentists as an area of concern and improvement for children.

CINCINNATI and AIRPORT CITY, Israel — SodaStream, a manufacturer of home beverage carbonation systems, announced that it has entered into an agreement with Sunny Delight Beverages Co., a producer of juice-based drinks. The companies will co-develop flavors like SunnyD Tangy Original Orange and Orange-Strawberry exclusively for the SodaStream system.

BOSTON — Somersets, a line of shaving and skincare products from the United Kingdom, has announced a new retail partnership with Walgreens, beginning this month.

In support of the new distribution, Somersets will highlight Walgreens in promotional materials as well as a social media campaign. Products available at the launch locations include:


MUMBAI and BALTIMORE — Lupin on Wednesday announced that it received approval from the Food and Drug Administration for rifabutin capsules USP, 150 mg — a generic version of Pharmacia and Upjohn Company's Mycobutin capsules. The company's U.S. subsidiary will begin marketing the product soon.

The drug is used for the prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infection. Mycobutin capsules had annual sales of $18.6 million in the United States, according to IMS MAT.

WASHINGTON — To provide pharmacist a detail description of each step in the comprehensive medication review, the American Pharmacists Association has published How to Conduct a Comprehensive Medication Review: A Guidebook for Pharmacists, the association has announced.

The new guide covers such areas as: